These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25765691)

  • 1. [Regulatory T cells in systemic lupus erythematosus].
    Okamura T; Morita K; Fujio K; Yamamoto K
    Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(1):69-77. PubMed ID: 25765691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of LAG3 and EGR2 in regulatory T cells.
    Okamura T; Fujio K; Sumitomo S; Yamamoto K
    Ann Rheum Dis; 2012 Apr; 71 Suppl 2():i96-100. PubMed ID: 22460149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Growth Response Gene 2-Expressing CD4
    Okamura T; Yamamoto K; Fujio K
    Front Immunol; 2018; 9():340. PubMed ID: 29535721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4
    Peixoto TV; Carrasco S; Botte DAC; Catanozi S; Parra ER; Lima TM; Ugriumov N; Soriano FG; de Mello SBV; Rodrigues CM; Goldenstein-Schainberg C
    Adv Rheumatol; 2019 Jul; 59(1):30. PubMed ID: 31340848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4(+)FoxP3(+) regulatory T-cells in human systemic lupus erythematosus.
    Suen JL; Chiang BL
    J Formos Med Assoc; 2012 Sep; 111(9):465-70. PubMed ID: 23021502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two separate effects contribute to regulatory T cell defect in systemic lupus erythematosus patients and their unaffected relatives.
    Costa N; Marques O; Godinho SI; Carvalho C; Leal B; Figueiredo AM; Vasconcelos C; Marinho A; Moraes-Fontes MF; Gomes da Costa A; Ponte C; Campanilho-Marques R; Cóias T; Martins AR; Viana JF; Lima M; Martins B; Fesel C
    Clin Exp Immunol; 2017 Sep; 189(3):318-330. PubMed ID: 28542701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosus.
    Sobel ES; Brusko TM; Butfiloski EJ; Hou W; Li S; Cuda CM; Abid AN; Reeves WH; Morel L
    Arthritis Res Ther; 2011 Jun; 13(3):R106. PubMed ID: 21708033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Y27, a novel derivative of 4-hydroxyquinoline-3-formamide, prevents the development of murine systemic lupus erythematosus-like diseases in MRL/lpr autoimmune mice and BDF1 hybrid mice.
    Xiao ZY; Chen SH; Cheng JP; Zhou WX; Zhang YX; Yang RF; Yun LH
    Arthritis Res Ther; 2012 Nov; 14(6):R235. PubMed ID: 23116248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-regs in autoimmune hepatitis-systemic lupus erythematosus/mixed connective tissue disease overlap syndrome are functionally defective and display a Th1 cytokine profile.
    Longhi MS; Ma Y; Grant CR; Samyn M; Gordon P; Mieli-Vergani G; Vergani D
    J Autoimmun; 2013 Mar; 41():146-51. PubMed ID: 23287048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identity of mysterious CD4+CD25-Foxp3+ cells in SLE.
    Horwitz DA
    Arthritis Res Ther; 2010; 12(1):101. PubMed ID: 20122288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
    Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N
    Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low frequency of CD4+CD25+ Treg in SLE patients: a heritable trait associated with CTLA4 and TGFbeta gene variants.
    Barreto M; Ferreira RC; Lourenço L; Moraes-Fontes MF; Santos E; Alves M; Carvalho C; Martins B; Andreia R; Viana JF; Vasconcelos C; Mota-Vieira L; Ferreira C; Demengeot J; Vicente AM
    BMC Immunol; 2009 Jan; 10():5. PubMed ID: 19173720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced number and function of CD4+CD25highFoxP3+ regulatory T cells in patients with systemic lupus erythematosus.
    Lyssuk EY; Torgashina AV; Soloviev SK; Nassonov EL; Bykovskaia SN
    Adv Exp Med Biol; 2007; 601():113-9. PubMed ID: 17712998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of FOXP3
    Schmidt A; Rieger CC; Venigalla RK; Éliás S; Max R; Lorenz HM; Gröne HJ; Krammer PH; Kuhn A
    Immunol Res; 2017 Apr; 65(2):551-563. PubMed ID: 28224362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of CD4+CD25high regulatory T-cells and FoxP3 expression in the peripheral blood of patients with systemic lupus erythematosus.
    Atfy M; Amr GE; Elnaggar AM; Labib HA; Esh A; Elokely AM
    Egypt J Immunol; 2009; 16(1):117-26. PubMed ID: 20726328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relation of CD4
    Kamal M; Gabr H; Anwar S; Bastawy S; Salah L
    Lupus; 2022 Apr; 31(4):463-471. PubMed ID: 35249399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus.
    Valencia X; Yarboro C; Illei G; Lipsky PE
    J Immunol; 2007 Feb; 178(4):2579-88. PubMed ID: 17277168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T-cell-associated cytokines in systemic lupus erythematosus.
    Okamoto A; Fujio K; Okamura T; Yamamoto K
    J Biomed Biotechnol; 2011; 2011():463412. PubMed ID: 22219657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of forkhead box P3 levels in CD4+CD25high T cells in patients with new-onset systemic lupus erythematosus.
    Zhang B; Zhang X; Tang F; Zhu L; Liu Y
    Clin Exp Immunol; 2008 Aug; 153(2):182-7. PubMed ID: 18505426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25(high)FoxP3+ regulatory T cells during repeated plasmapheresis treatments of patients.
    Baráth S; Soltész P; Kiss E; Aleksza M; Zeher M; Szegedi G; Sipka S
    Autoimmunity; 2007 Nov; 40(7):521-8. PubMed ID: 17966042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.